0000899243-22-004128.txt : 20220202
0000899243-22-004128.hdr.sgml : 20220202
20220202160522
ACCESSION NUMBER: 0000899243-22-004128
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McDonough Brian
CENTRAL INDEX KEY: 0001605065
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36415
FILM NUMBER: 22583603
MAIL ADDRESS:
STREET 1: 12521 MARET DRIVE
CITY: ST. LOUIS
STATE: MO
ZIP: 63127
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quotient Ltd
CENTRAL INDEX KEY: 0001596946
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 264719797
STATE OF INCORPORATION: Y9
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
BUSINESS PHONE: 41274832286
MAIL ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-31
0
0001596946
Quotient Ltd
QTNT
0001605065
McDonough Brian
28 ESPLANADE
ST HELIER
Y9
JE2 3QA
JERSEY
1
0
0
0
Ordinary Shares
2022-01-31
4
S
0
1886
D
66901
D
Ordinary Shares
2022-01-31
4
M
0
6917
A
68787
D
Ordinary Shares
53040
I
By the McDonough-McGuire Joint Revocable Trust
Ordinary Shares Option (Right to buy)
8.00
2024-04-29
Ordinary Shares
10000
10000
D
Options to purchase ordinary shares
2014-11-14
2022-08-30
Ordinary Shares
40029
40029
D
Ordinary Shares Option (Right to buy)
9.95
2024-10-31
Ordinary Shares
5025
5025
D
Ordinary Shares Option(Right to buy)
11.62
2025-10-31
Ordinary Shares
4303
4303
D
Ordinary Shares Option(Right to buy)
5.73
2026-10-31
Ordinary Shares
8726
8726
D
Ordinary Shares Option (Right to buy)
5.21
2027-10-31
Ordinary Shares
9597
9597
D
Ordinary Shares Option (Right to buy)
6.41
2028-10-31
Ordinary Shares
6240
6240
D
Ordinary Shares Option (Right to buy)
7.78
2029-10-31
Ordinary Shares
8158
8158
D
Ordinary Share Option(Right to Buy)
4.55
2030-10-31
Ordinary Shares
13611
13611
D
Restricted Stock Units
2022-01-31
4
M
0
6917
0.00
D
Ordinary Shares
6917
20751
D
Ordinary Share Option (Right to Buy)
2.53
2031-10-31
Ordinary Shares
24040
24040
D
All 10,000 options have vested and remain exercisable.
The exercise price will be paid in pounds sterling, at GBP 0.91 per share.
All 5,025 options have vested and remain exercisable.
All 4,303 options have vested and remain exercisable.
All 8,726 options have vested and remain exercisable.
Restricted Stock Units convert into ordinary shares on a one-for-one basis.
All 9,597 options have vested and remain exercisable.
All 6,240 options have vested and remain exercisable.
The Reporting Person and his spouse are Co-Trustees of their successors in trust, of the McDonough-McGuire Joint Revocable Trust, dated May 14, 2013. The Reporting Person disclaims beneficialownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these ordinary shares in this report shall not be deemed an admission of beneficial ownership of all of thereported ordinary shares for purposes of Section 16 or for any other purpose.
2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022.
All 13,611 options have vested and remain exercisable.
On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 6,917 have vested and have converted into ordinary shares. The remaining 20,751 restricted stock units will vest in three equal installments on April 30, 2022, July 31, 2022 and October 31, 2022.
The options vest and become exercisable on October 31, 2022.
The sale reported on this Form 4 is a sale to cover taxes arising from the vesting and settlement of RSU awards. This sale is mandated by the Reporting Person's election to fund such taxes by completing a"sell to cover" transaction with a brokerage firm designated by the Issuer.
/s/ Brian McDonough
2022-02-02